透明质酸钠结构式
|
常用名 | 透明质酸钠 | 英文名 | Sodium Hyaluronate |
|---|---|---|---|---|
| CAS号 | 9067-32-7 | 分子量 | 799.63800 | |
| 密度 | 1.78g/cm3 | 沸点 | 791.6ºC | |
| 分子式 | C14H22NNaO11 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | 432.5ºC |
|
The effects of biological lubricating molecules on flexor tendon reconstruction in a canine allograft model in vivo.
Plast. Reconstr. Surg. 133(5) , 628e-637e, (2014) Using allograft is an attractive alternative for flexor tendon reconstruction because of the lack of donor-site morbidity, and better matching to the intrasynovial environment. The purpose of this study was to use biological lubricant molecules to modify the ... |
|
|
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.
Clin. Cancer Res. 21 , 2753-62, (2015) CD44, a cell surface glycoprotein, plays important roles in the development, progression, and metastasis of various tumor types. The aim of this study was to investigate how the expression of CD44 isoforms influences the interaction with hyaluronic acid (HA) ... |
|
|
Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements.
Infect. Immun. 82(12) , 5293-307, (2014) The important human pathogen Streptococcus pyogenes (group A Streptococcus [GAS]) produces a hyaluronic acid (HA) capsule that plays critical roles in immune evasion. Previous studies showed that the hasABC operon encoding the capsule biosynthesis enzymes is ... |
|
|
Late Ureteral Obstruction After Injection of Dextranomer/Hyaluronic Acid Copolymer
Urology 83(4) , 920-2, (2014) Various biological and artificial materials have been introduced for endoscopic treatment of vesicoureteral reflux. Over the past years, dextranomer combined with hyaluronic acid (Dx/Ha) has been established as the most commonly used tissue-augmenting substan... |
|
|
Recent trends in the surgical management of primary vesicoureteral reflux in the era of dextranomer/hyaluronic acid.
J. Urol. 191(5 Suppl) , 1628-33, (2014) Since its inception as a technology in the United States, endoscopic correction of vesicoureteral reflux has become a popular treatment option in children with vesicoureteral reflux with reported wide use. We determined whether the increasing trend in use in ... |
|
|
Current trends in dextranomer hyaluronic acid copolymer (Deflux) injection technique for endoscopic treatment of vesicoureteral reflux.
Urology 84(2) , 462-8, (2014) To determine the current preferred injection technique(s) for endoscopic management of pediatric vesicoureteral reflux (VUR). Since the approval of dextranomer hyaluronic acid copolymer (Dx/HA) in 2001, injection methods have evolved and now include the hydro... |
|
|
Editorial comment.
J. Urol. 191(5 Suppl) , 1633; discussion 1633, (2014)
|
|
|
Editorial comment.
Urology 83(4) , 922-3, (2014)
|
|
|
Re: delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (deflux) injection for treatment of vesicoureteral reflux in children: a case series.
J. Urol. 191(5) , 1409, (2014)
|
|
|
Re: acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage.
J. Urol. 191(5) , 1407-8, (2014)
|